HALEEMA OSMANI: Open Payments
NPI 1588392278 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,915 in 72 payments from 22 companies in 2025. Trend: 2023 $945 · 2024 $2,101 · 2025 $1,915
Food & beverage: $1,915
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $416 |
| Lilly USA, LLC | 10 | $327 |
| Novo Nordisk Inc | 10 | $211 |
| Phathom Pharmaceuticals, Inc. | 2 | $143 |
| ABBVIE INC. | 7 | $136 |
| Lundbeck LLC | 5 | $117 |
| Exact Sciences Corporation | 3 | $75 |
| Corcept Therapeutics | 2 | $64 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
Products named: AIRSUPRA, MOUNJARO, BREZTRI, VOQUEZNA, ZEPBOUND, REXULTI, UBRELVY, Ozempic.
Industry payments across NY — which companies pay providers there.
